What should we do to improve patients' adherence?

Journal of Experimental and Clinical Medicine(Taiwan)

Volumn 5, Issue 4, 2013, Pages 127-130

  Ito, Hiroto ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Adherence; Compliance; Medication management and use; Shared decision making

Indexed keywords

CASE MANAGEMENT; DECISION MAKING; DOCTOR PATIENT RELATION; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH LITERACY; HUMAN; MEDICAL CARE; MEDICATION COMPLIANCE; MOTIVATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT PREFERENCE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; REIMBURSEMENT; REVIEW; SELF REPORT; SYSTEMATIC REVIEW (TOPIC);

EID: 84883455192     PISSN: 18783317     EISSN: 18783325     Source Type: Journal    
DOI: 10.1016/j.jecm.2013.05.001     Document Type: Review

References (62)

1. Chisholm-Burns M.A., Spivey C.A. The "cost" of medication nonadherence: consequences we cannot afford to accept. JAm Pharm Assoc 2012, 52:823-826.
2. Adherence to long-term therapies: evidence for action 2003, World Health Organization, World Health Organization, Geneva.
3. Osterberg L., Blaschke T. Adherence to medication. NEngl J Med 2005, 353:487-497.
4. Haynes R.B., Ackloo E., Sahota N., McDonald H.P., Yao X. Cochrane Database Syst Rev 2008, 2:CD000011.
5. Benner J.S., Glynn R.J., Mogun H., Neumann P.J., Weinstein M.C., Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002, 288:455-461.
6. DiMatteo M.R. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004, 42:200-209.
7. Feinstein A. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990, 150:377-378.
8. Cramer J.A., Scheyer R.D., Mattson R.H. Compliance declines between clinic visits. Arch Intern Med 1990, 150:509-510.
9. Murri R., Ammassari A., Trotta M.P., Luca A.D., Melzi S., Minardi C., Zaccarelli M., et al. Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance. JGen Intern Med 2004, 19:1104-1110.
10. Schiff G.D., Fung S., Speroff T., McNutt R.A. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med 2003, 114:625-630.
11. Vermeire E., Hearnshaw H., Van Royen P., Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. JClin Pharm Ther 2001, 26:331-342.
12. Peterson A.M., Takiya L., Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003, 60:657-665.
13. Sokol M.C., McGuigan K.A., Verbrugge R.R., Epstein R.S. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005, 43:521-530.
14. Wens J., Vermeire E., Royen P.V., Sabbe B., Denekens J. GPs' perspectives of type 2 diabetes patients' adherence to treatment: a qualitative analysis of barriers and solutions. BMC Fam Pract 2005, 6:20.
15. Gehi A., Haas D., Pipkin S., Whooley M.A. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul study. Arch Intern Med 2005, 165:2508-2513.
16. DiMatteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101-2107.
17. Zolnierek K.B., Dimatteo M.R. Physician communication and patient adherence to treatment: a meta-analysis. Med Care 2009, 47:826-834.
18. Viswanathan M., Golin C.E., Jones C.D., Ashok M., Blalock S.J., Wines R.C., Coker-Schwimmer E.J., et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med 2012, 157:785-795.
19. Bubalo J., Clark R.K., Jiing S.S., Johnson N.B., Miller K.A., Clemens-Shipman C.J., et al. Medication adherence: pharmacist perspective. JAm Pharm Assoc 2010, 50:394-406.
20. MacLaughlin E.J., Raehl C.L., Treadway A.K., Sterling T.L., Zoller D.P., Bond C.A. Assessing medication adherence in the elderly: which tools to use in clinical practice?. Drugs Aging 2005, 22:231-255.
21. Ruddy K., Mayer E., Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 2009, 59:56-66.
22. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
23. Risser J., Jacobson T.A., Kripalani S. Development and psychometric evaluation of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease. JNurs Meas 2007, 15:203-219.
24. Svarstad B.L., Chewing B.A., Sleath B.L., Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999, 37:113-124.
25. Kim M.T., Hill M.N., Bone L.R., Levine D.M. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs 2000, 15:90-96.
26. Thompson K., Kulkarni J., Sergejew A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000, 42:241-247.
27. Lavsa S.M., Holzworth A., Ansani N.T. Selection of a validated scale for measuring medication adherence. JAm Pharm Assoc 2011, 51:90-94.
28. McMahon J.H., Jordan M.R., Kelley K., Bertagnolio S., Hong S.Y., Christine A., Wanke C.A., et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis 2011, 52:493-506.
29. Sikka R., Xia F., Aubert R.E. Estimating medication persistency using administrative claims data. Am J Manag Care 2005, 11:449-457.
30. Steiner J.F., Prochazka A.V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. JClin Epidemiol 1997, 50:105-116.
31. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999, 21:1074-1090.
32. George C.F., Peveler R.C., Heiliger S., Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 2000, 50:166-171.
33. Roter D.L., Hall J.A., Merisca R., Ruehle B., Cretin D., Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Medical Care 1998, 36:1138-1161.
34. Ingersoll K.S., Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. JBehav Med 2008, 31:213-224.
35. Claxton A.J., Cramer J., Pierce C. Asystematic review of the associations between dose regimens and medication compliance. Clin Ther 2001, 23:1296-1310.
36. Conn V.S., Hafdahl A.R., Cooper P.S., Ruppar T.M., Mehr D.R., Russell C.L. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist 2009, 49:447-462.
37. Topinková E., Baeyens J.P., Michel J.P., Lang P.O. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging 2012, 29:477-494.
38. Davis T.C., Federman A.D., Bass P.F., Jackson R.H., Middlebrooks M., Parker R.M., Wolf M.S. Improving patient understanding of prescription drug label instructions. JGen Intern Med 2009, 24:57-62.
39. Health literacy: a prescription to end confusion 2004, Institute of Medicine of the National Academies, National Academies Press, Washington DC.
40. Witticke D., Seidling H.M., Lohmann K., Send A.F., Haefeli W.E. Opportunities to reduce medication regimen complexity: a retrospective analysis of patients discharged from a university hospital in Germany. Drug Saf 2013, 36:31-41.
41. Fulmer T.T., Feldman P.H., Kim T.S., Carty B., Beers M., Molina M., Putnam M. An intervention study to enhance medication compliance in community dwelling elderly individuals. JGerontol Nurs 1999, 25:6-14.
42. Hoffman L., Enders J., Luo J., Segal R., Pippins J., Kimberlin C. Impact of an antidepressant management program on medication adherence. Am J Manag Care 2003, 9:70-80.
43. Schedlbauer A., Schroeder K., Fahey T. How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials. Fam Pract 2007, 24:380-387.
44. Schedlbauer A., Davies P., Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev 2010, 17:CD004371.
45. Hasvold P.E., Wootton R. Use of telephone and SMS reminders to improve attendance at hospital appointments: a systematic review. JTelemed Telecare 2011, 17:358-364.
46. Chapman R.H., Ferrufino C.P., Kowal S.L., Classi P., Roberts C.S. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs. Int J Clin Pract 2010, 64:169-181.
47. Bogner H.R., de Vries H.F. Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial. Diabetes Educ 2010, 36:284-292.
48. Bogner H.R., Morales K.H., de Vries H.F., Cappola A.R. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Ann Fam Med 2012, 10:15-22.
49. Bogner H.R., de Vries H.F. Integration of depression and hypertension treatment: a pilot, randomized controlled trial. Ann Fam Med 2008, 6:295-301.
50. Rich M.W., Gray D.B., Beckham V., Wittenberg C., Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996, 101:270-276.
51. Katon W., Rutter C., Ludman E.J., Von Korff M., Lin E., Simon G., Bush T., et al. Arandomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry 2001, 58:241-247.
52. Ludman E., Katon W., Bush T., Rutter C., Lin E., Simon G., Von Korff M., et al. Behavioural factors associated with symptom outcomes in a primary care-based depression prevention intervention trial. Psychol Med 2003, 33:1061-1070.
53. Von Korff M., Katon W., Rutter C., Ludman E., Simon G., Lin E., Bush T. Effect on disability outcomes of a depression relapse prevention program. Psychosom Med 2003, 65:938-943.
54. Katon W.J., Lin E.H., Von Korff M., Ciechanowski P., Ludman E.J., Young B., Peterson D., et al. Collaborative care for patients with depression and chronic illnesses. NEngl J Med 2010, 363:2611-2620.
55. Katon W., Von Korff M., Lin E., Simon G.E. Rethinking practitioner roles in chronic illness: the specialist primary care physician and the practice nurse. Gen Hosp Psychiatry 2001, 23:138-144.
56. Gilbody S., Bower P., Fletcher J., Richards D., Sutton A.J. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcome. Arch Intern Med 2006, 166:2314-2321.
57. Murray M.D., Young J., Hoke S., Tu W., Weiner M., Morrow D., Stroupe K.T., et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med 2007, 146:714-725.
58. Okeke C.O., Quigley H.A., Jampel H.D., Ying G.S., Plyler R.J., Jiang Y., Friedman D.S. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology 2009, 116:2286-2293.
59. Sandman L., Granger B.B., Ekman I., Munthe C. Adherence, shared decision-making and patient autonomy. Med Health Care Philos 2012, 15:115-127.
60. Barry M.J., Edgman-Levitan S. Shared decision making: pinnacle of patient-centered care. NEngl J Med 2012, 366:780-781.
61. Ratanawongsa N., Karter A.J., Parker M.M., Lyles C.R., Heisler M., Moffet H.H., Adler N., et al. Communication and medication refill adherence: the Diabetes Study of Northern California. JAMA Intern Med 2013, 173:210-218.
62. Oshima Lee E., Emanuel E.J. Shared decision making to improve care and reduce costs. NEngl J Med 2013, 368:6-8.